Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-002664
Filing Date
2016-06-20
Accepted
2016-06-20 16:07:55
Documents
1
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4550
  Complete submission text file 0001562180-16-002664.txt   5957
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02109
Business Address
Renaud Ronald C JR (Reporting) CIK: 0001354434 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 161722215

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations